Annovis Bio, Inc. Research and Development Expense
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- Annovis Bio, Inc. research and development expense for the quarter ending 2026-06-30 was $12.01M, a 132.61% increase year-over-year.
- Annovis Bio, Inc. research and development expense for the quarter ending 2026-03-31 was $16.72M, a 233.64% increase year-over-year.
- Annovis Bio, Inc. research and development expense for the quarter ending 2025-12-31 was $8.75M, a 75.07% increase year-over-year.
- Annovis Bio, Inc. research and development expense for the quarter ending 2025-09-30 was $6.29M, a 133.91% increase year-over-year.
- Annovis Bio, Inc. research and development expense for fiscal 2025 was $25.22M, a 26.11% increase from fiscal 2024.
- Annovis Bio, Inc. research and development expense for fiscal 2024 was $20.00M, a 48.45% decline from fiscal 2023.
- Annovis Bio, Inc. research and development expense for fiscal 2023 was $38.79M, a 134.87% increase from fiscal 2022.
- Annovis Bio, Inc. research and development expense for fiscal 2022 was $16.52M, a 94.78% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $12.01M 10-Q · filed 2026-08-14 | $28.73M 10-Q · filed 2026-08-14 | $37.48M derived: sum of 3 quarters · filed 2026-08-14 | $43.77M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $16.72M 10-Q · filed 2026-05-15 | $25.47M derived: sum of 2 quarters · filed 2026-05-15 | $31.76M derived: sum of 3 quarters · filed 2026-05-15 | $36.92M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $8.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $15.04M derived: sum of 2 quarters · filed 2026-03-13 | $20.20M derived: sum of 3 quarters · filed 2026-08-14 | $25.22M 10-K · filed 2026-03-13 | |||
| 2025-09-30 | $6.29M 10-Q · filed 2025-11-12 | $11.45M derived: sum of 2 quarters · filed 2026-08-14 | $16.46M 10-Q · filed 2025-11-12 | $21.46M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $5.16M 10-Q · filed 2026-08-14 | $10.17M 10-Q · filed 2026-08-14 | $15.17M derived: sum of 3 quarters · filed 2026-08-14 | $17.86M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $5.01M 10-Q · filed 2026-05-15 | $10.01M derived: sum of 2 quarters · filed 2026-05-15 | $12.70M derived: sum of 3 quarters · filed 2026-05-15 | $18.48M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $7.69M derived: sum of 2 quarters · filed 2026-03-13 | $13.47M derived: sum of 3 quarters · filed 2026-03-13 | $20.00M 10-K · filed 2026-03-13 | |||
| 2024-09-30 | $2.69M 10-Q · filed 2025-11-12 | $8.47M derived: sum of 2 quarters · filed 2025-11-12 | $15.00M 10-Q · filed 2025-11-12 | $23.89M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $5.79M 10-Q · filed 2025-08-12 | $12.31M 10-Q · filed 2025-08-12 | $21.20M derived: sum of 3 quarters · filed 2025-08-12 | $35.04M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $6.51M 10-Q · filed 2025-05-13 | $15.42M derived: sum of 2 quarters · filed 2025-05-13 | $29.26M derived: sum of 3 quarters · filed 2025-05-13 | $37.52M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $22.74M derived: sum of 2 quarters · filed 2025-03-21 | $31.00M derived: sum of 3 quarters · filed 2025-03-21 | $38.79M 10-K · filed 2025-03-21 | |||
| 2023-09-30 | $13.84M 10-Q · filed 2024-11-08 | $22.10M derived: sum of 2 quarters · filed 2024-11-08 | $29.89M 10-Q · filed 2024-11-08 | $36.09M derived: sum of 4 quarters · filed 2024-11-08 | |||
| 2023-06-30 | $8.26M 10-Q · filed 2024-08-14 | $16.05M 10-Q · filed 2024-08-14 | $22.26M derived: sum of 3 quarters · filed 2024-08-14 | $26.38M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $7.79M 10-Q · filed 2024-05-10 | $13.99M derived: sum of 2 quarters · filed 2024-05-10 | $18.12M derived: sum of 3 quarters · filed 2024-05-10 | $22.15M derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $6.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $10.33M derived: sum of 2 quarters · filed 2024-03-29 | $14.37M derived: sum of 3 quarters · filed 2024-03-29 | $16.52M 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $4.12M 10-Q · filed 2023-11-08 | $5.31M 10-Q · filed 2022-11-08 | $8.16M derived: sum of 2 quarters · filed 2023-11-08 | $10.31M 10-Q · filed 2023-11-08 | $14.94M 10-Q · filed 2022-11-08 | $13.19M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $4.03M 10-Q · filed 2023-08-14 | $6.82M 10-Q · filed 2022-08-08 | $6.18M 10-Q · filed 2023-08-14 | $9.63M 10-Q · filed 2022-08-08 | $9.07M derived: sum of 3 quarters · filed 2023-08-14 | $10.45M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $2.15M 10-Q · filed 2023-05-10 | $2.81M 10-Q · filed 2022-05-04 | $5.03M derived: sum of 2 quarters · filed 2023-05-10 | $6.41M derived: sum of 3 quarters · filed 2023-05-10 | $8.24M derived: sum of 4 quarters · filed 2023-05-10 | ||
| 2021-12-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $4.26M derived: sum of 2 quarters · filed 2023-03-31 | $6.09M derived: sum of 3 quarters · filed 2023-03-31 | $8.48M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $1.38M 10-Q · filed 2022-11-08 | $3.21M derived: sum of 2 quarters · filed 2022-11-08 | $5.59M 10-Q · filed 2022-11-08 | $7.01M derived: sum of 4 quarters · filed 2022-11-08 | |||
| 2021-06-30 | $1.82M 10-Q · filed 2022-08-08 | $4.21M 10-Q · filed 2022-08-08 | $5.63M derived: sum of 3 quarters · filed 2022-08-08 | $6.35M derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2021-03-31 | $2.39M 10-Q · filed 2022-05-04 | $3.80M derived: sum of 2 quarters · filed 2022-05-04 | $4.52M derived: sum of 3 quarters · filed 2022-05-04 | $5.38M derived: sum of 4 quarters · filed 2022-05-04 | |||
| 2020-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $2.13M derived: sum of 2 quarters · filed 2022-03-02 | $2.99M derived: sum of 3 quarters · filed 2022-03-02 | $3.05M 10-K · filed 2022-03-02 | |||
| 2020-09-30 | $718.90K 10-Q · filed 2021-11-03 | $1.58M derived: sum of 2 quarters · filed 2021-11-03 | $1.64M 10-Q · filed 2021-11-03 | $2.40M derived: sum of 4 quarters · filed 2021-11-03 | |||
| 2020-06-30 | $856.48K 10-Q · filed 2021-07-28 | $922.92K 10-Q · filed 2021-07-28 | $1.69M derived: sum of 3 quarters · filed 2021-07-28 | $1.69M derived: sum of 4 quarters · filed 2021-07-28 | |||
| 2020-03-31 | $66.45K 10-Q · filed 2021-05-06 | $828.63K derived: sum of 2 quarters · filed 2021-05-06 | $830.64K derived: sum of 3 quarters · filed 2021-05-06 | $836.68K derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | $762.18K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $764.20K derived: sum of 2 quarters · filed 2021-03-03 | $770.24K derived: sum of 3 quarters · filed 2021-03-03 | $776.26K 10-K · filed 2021-03-03 | |||
| 2019-09-30 | $2.01K 10-Q · filed 2020-11-04 | $8.05K derived: sum of 2 quarters · filed 2020-11-04 | $14.07K 10-Q · filed 2020-11-04 | ||||
| 2019-06-30 | $6.04K 10-Q · filed 2020-07-29 | $12.06K 10-Q · filed 2020-07-29 | |||||
| 2019-03-31 | $6.02K 10-Q · filed 2020-05-05 |